Application no. and date | 19830950.2 (espacenet) (Federated) (European Patent Register), 20190701 | Patent/reg. no. and date | DK/EP 3817751, 20250618 | Publication date | 20210512 | Priority no. and date | US 201862693502 P, 20180703, US 201862693503 P, 20180703 | EP pub. no. and date |
EP 3817751 20210512 | Effective date | | Applicant/owner | Fennec Pharmaceuticals, Inc., 68 TW Alexander Drive
Research Triangle Park NC 27709, US | Applicant ref. no. | V2506-025-DK | Inventor | SMITH, Alexander,
Apex NC27502, US | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | Opponent | | IPC Class | A61K 33/04 (2006.01) , A61K 47/02 (2006.01) , A61K 47/18 (2017.01) , A61K 47/20 (2006.01) , A61K 9/00 (2006.01) , A61K 9/08 (2006.01) , A61K 9/19 (2006.01) , A61P 35/00 (2006.01) , C01B 17/64 (2006.01) | Title | FORMULERINGER AF VANDFRIT NATRIUMTHIOSULFAT | Int. application no. | US2019040052 | Int. publication no. | WO2020009954 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|